Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
03/2014
03/18/2014US8674100 Inhibitors of C-FMS kinase
03/18/2014US8674090 Benzimidazole derivatives as PI3 kinase inhibitors
03/18/2014US8673955 Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
03/18/2014US8673948 Chemical compounds
03/18/2014US8673920 Inhibitors of the renal outer medullary potassium channel
03/18/2014US8673912 Crystalline Forms on N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
03/18/2014US8673911 Inhibitors of histone deacetylase
03/18/2014US8673908 Kynurenine production inhibitor
03/18/2014US8673907 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6-amino- 2-butoxy-8-oxo-7,8-dihydro-9H-purin-9-yl) propyl] (3-morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
03/18/2014US8673905 Imidazo pyrazines
03/18/2014US8673899 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
03/18/2014US8673894 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/18/2014US8673891 Aminopyrazine derivative and medicine
03/18/2014CA2637590C Treatment of inflammatory disorders with triazole compounds
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
03/13/2014WO2014037751A1 Pharmacologically active compounds
03/13/2014WO2014037750A1 Inhibitor compounds
03/13/2014WO2014037480A1 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
03/13/2014WO2014037342A1 Herbicidally active bicycloaryl carboxylic acid amides
03/13/2014WO2014037327A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof
03/13/2014WO2014036595A1 Compounds and methods for treating diseases or conditions associated with the central nervous system and/or neurite outgrowth
03/13/2014WO2014016849A9 Novel triazine compounds
03/13/2014WO2014015167A3 5,5-heteroaromatic anti-infective compounds
03/13/2014WO2013188813A3 Novel therapeutics for brain cancer
03/13/2014US20140073783 Neprilysin inhibitors
03/13/2014US20140073658 Dipyridylamine Derivative
03/13/2014US20140073650 Proteasome chymotrypsin-like inhibition using pi-1833 analogs
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/13/2014US20140073636 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
03/13/2014US20140073634 Heterocyclic modulators of hif activity for treatment of disease
03/13/2014US20140073628 Benzoxazepines asn inhibitors of p13k/m tor and methods of their use and manufacture
03/13/2014US20140073624 Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
03/13/2014US20140073622 Imidazole carbonyl compound
03/13/2014US20140073620 Vegfr3 inhibitors
03/12/2014EP2705181A1 Combination pharmaceutical compositions and uses thereof
03/12/2014EP2705034A1 Crystalline sodium salt of an hiv integrase inhibitor
03/12/2014EP2705028A1 Process for the preparation of a rivaroxaban and intermediates formed in said process
03/12/2014EP2704712A1 Isoxazolines as therapeutic agents
03/12/2014CN103635467A Oxazepines as ion channel modulators
03/12/2014CN103635458A Trpv1 antagonists
03/12/2014CN103626752A Dihydropyrimidine compounds and application of same in drugs
03/12/2014CN103626749A Substituted oxazolidinone compound, and pharmaceutical composition containing compound and application thereof
03/12/2014CN103626748A Oxadiazole compound containing pyridine, and preparation method and application of oxadiazole compound containing pyridine
03/12/2014CN103626713A Aza (oxa)-cyclopentane-2- ketone (thione) compounds, medicine compositions thereof, preparation method and applications
03/12/2014CN103626630A Rivaroxaban intermediate and preparation method thereof
03/12/2014CN102395579B Hepatitis c virus inhibitors
03/12/2014CN102351853B Azilsartan medoxomil compound, preparation method and medicinal composition thereof
03/12/2014CN102325754B Cyclic compound having hetero atom
03/12/2014CN102206214B Benzopyrone derivative and application thereof
03/12/2014CN101935303B Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
03/12/2014CN101903378B Aminotriazole derivatives
03/11/2014US8669252 Prolylcarboxypeptidase inhibitors
03/11/2014US8669251 8-fluorophthalazin-1(2H)-one compounds
03/11/2014US8669250 Derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
03/11/2014US8669249 Poly (ADP-ribose) polymerase (PARP) inhibitors
03/11/2014US8669248 Adenine inhibitors of HSP90
03/11/2014US8669234 Antiviral compounds
03/11/2014US8669208 Herbicidal benzoxazinones
03/11/2014US8669081 Compositions useful as inhibitors of protein kinases
03/11/2014US8669072 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/11/2014CA2784180C Seven-membered ring compound and pharmaceutical use therefor
03/11/2014CA2691056C Bromo-phenyl substituted thiazolyl dihydropyrimidines for treating and preventing hepatitis b infections
03/11/2014CA2501932C Use of benzimidazole quinolinones for treating cancer
03/06/2014WO2014036022A1 Quinazolinone compounds and derivatives thereof
03/06/2014WO2014035872A1 Tricyclic alkynes that interact with glucokinase regulatory protein
03/06/2014WO2014034898A1 Pyridine derivative and medicine
03/06/2014WO2014034535A1 Light emitting material, compound and organic light emitting element using light emitting material
03/06/2014WO2014034348A1 Heterocyclic compound, metal complex and fluorescent probe
03/06/2014WO2014033740A1 Novel polymorphs of azilsartan medoxomil
03/06/2014WO2014033448A1 Pyrazole derivatives as p38 map inhibitors
03/06/2014WO2014032801A1 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140066457 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
03/06/2014US20140066443 Aminomethyl biaryl benzotriazole derivatives
03/06/2014US20140066432 Substituted Benzoazepines As Toll-Like Receptor Modulators
03/06/2014US20140066427 S1P Receptors Modulators and Their Use Thereof
03/06/2014US20140066426 Fluoromethyl-substituted pyrrole carboxamides
03/06/2014US20140066425 Androgen receptor antagonists and uses thereof
03/06/2014US20140066424 Heterocyclic modulators of hif activity for treatment of disease
03/06/2014US20140066420 Heterocyclic compound
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
03/06/2014US20140066407 Fungicide Active Substance Combinations
03/06/2014US20140065103 Compounds and methods for the treatment or prevention of flaviviridae viral infections
03/06/2014US20140065095 Novel inhibitors
03/05/2014EP2703400A1 Phenyl pyrrole derivative crystal
03/05/2014EP2703399A1 Oxazine derivative and bace 1 inhibitor containing same
03/05/2014EP2703387A1 Cyclohexyl-substituted piperazine compounds
03/05/2014EP2702056A1 Derivatives of n- [(1h-pyrazol-1-yl) aryl]- 1h - indole or 1h - indazole - 3 - carboxamide, their preparation and their use as p2y12 antagonists
03/05/2014EP2702055A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
03/05/2014EP2702043A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
03/05/2014EP2702042A1 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/05/2014CN103619862A Glycoside derivatives and uses thereof
03/05/2014CN103619838A Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
03/05/2014CN103619837A Fatty acid amide hydrolase inhibitors for treating pain
03/05/2014CN103619834A Derivatives of N-[(1H-pyrazol-1-yl)aryl]-1H-indole or 1H-indazole-3-carboxamide, their preparation and their use as P2Y12 antagonists
03/05/2014CN103619824A Amide compound and pharmaceutical application therefor
03/05/2014CN103619817A Novel bicyclic nitrogen containing heteroaryl TGR5 receptor modulators
03/05/2014CN103613587A N,N-substituted 3-aminopyrrolidine compound capable of being used as monoamine reuptake inhibitor
03/05/2014CN103613585A Amorphous histone deacetylase inhibitor as well as preparation method and application thereof
03/05/2014CN103613584A Post-processing method of isradipine synthetic product
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 647